← 產業報告目錄

Ophthalmic Equipment Market by Technology (AI-enabled Equipment), Product Type (Surgical Devices (Ophthalmic Microscopes), Diagnostic & Monitoring Devices (Optical Coherence Tomography Scanners, Slit Lamps) ), End User (Hospitals) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-11-05頁數 474報告編號 MD2334

授權報價

Single User Licence$7,150 USD
Multi User Licence$8,500 USD
Corporate User Licence$9,650 USD
Global User Licence$11,000 USD
洽詢購買 申請 Sample

報告摘要

The ophthalmic equipment market is projected to reach USD 26.14 billion by 2030 from USD 19.65 billion in 2025, at a CAGR of 5.9% during the forecast period. The ophthalmic equipment market is mainly propelled by the increasing prevalence of eye conditions such as cataracts, glaucoma, and diabetic retinopathy, along with the aging global population. Rising use of advanced diagnostic tools like OCT and fundus cameras, higher healthcare expenditures, and broader access to eye care services in developing countries also drive market growth. Additionally, innovations in technology that support minimally invasive and AI-based eye care solutions boost adoption. However, high equipment costs and a shortage of skilled professionals limit market expansion. By product type, surgical devices dominate the ophthalmic equipment market because of the high volume of cataract, refractive, and glaucoma surgeries worldwide. Advances in microsurgical techniques, femtosecond lasers, and phacoemulsification systems have improved precision and outcomes, increasing their adoption. Additionally, the growing elderly population and the expanding availability of advanced surgical centers further boost demand for ophthalmic surgical devices. By end user, hospitals hold the largest share in the ophthalmic equipment market because they serve as primary centers for comprehensive eye care, providing both diagnostic and surgical services. They have advanced infrastructure and skilled ophthalmologists, and they attract more patients than clinics. Additionally, hospitals’ ability to invest in high-end ophthalmic equipment for complex procedures strengthens their dominance in the overall market. North America holds the largest share of the ophthalmic equipment market because of its advanced healthcare infrastructure, high adoption of innovative diagnostic and surgical technologies, and a strong presence of leading manufacturers. The region benefits from significant healthcare spending, supportive reimbursement policies, and a large number of trained ophthalmologists. Additionally, the increasing prevalence of age-related eye diseases like glaucoma and macular degeneration further boosts equipment demand, while ongoing innovation and early technology adoption help sustain the market dominance. A breakdown of the primary participants (supply-side) for the ophthalmic equipment market referred to in this report is provided below: • By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28% • By Designation: C-level: 26%, Director Level: 35%, and Others: 39% • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5% Prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (US), Carl Zeiss Meditec AG (Germany), Johnson & Johnson Vision Care (US), HOYA Corporation (Japan), EssilorLuxottica (France), Canon Inc. (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Staar Surgical (US), Haag-Streit (Switzerland), Visionix (France), Shanghai Mediworks Precision Instruments Co., Ltd. (China), Halma plc (UK), among others. Research Coverage The report assesses the ophthalmic equipment market and estimates its size and future growth potential across various segments, including technology, product type, end user, and region. It also provides a competitive analysis of the major players, featuring company profiles, product offerings, recent developments, and key market dynamics strategies. Reasons to Buy the Report The report will help market leaders and new entrants by providing data on approximate revenue figures for the overall market, the ophthalmic equipment sector, and its subsegments. It will assist stakeholders in understanding the competitive landscape and gaining insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse by offering data on key drivers, barriers, obstacles, and opportunities in the market. This report provides insights into the following points:  Analysis of key drivers (Increasing geriatric population, Rising prevalence of eye disorders, Technological advancements in ophthalmic devices, and Increased government initiatives to control visual impairment), restraints (High cost of ophthalmology devices, High cost and risk associated with eye surgeries and Rising adoption of refurbished ophthalmic devices), opportunities (Potential growth opportunities in emerging markets and Low adoption of phacoemulsification devices and premium IOLs in emerging markets), and challenges (Low accessibility to eye care in low-income countries, Lack of skilled professionals) • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ophthalmic equipment market • Market Development: Thorough knowledge and analysis of the profitable rising markets by technology, product type, end user, and region • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global ophthalmic equipment market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ophthalmic equipment market
目錄 Table of Contents
1 INTRODUCTION 38 1.1 STUDY OBJECTIVES 38 1.2 MARKET DEFINITION 38 1.3 STUDY SCOPE 39 1.3.1 SEGMENTS COVERED & REGIONAL SCOPE 39 1.3.2 INCLUSIONS & EXCLUSIONS 40 1.3.3 YEARS CONSIDERED 42 1.4 CURRENCY USED 42 1.5 STAKEHOLDERS 43 1.6 LIMITATIONS 43 1.7 SUMMARY OF CHANGES 43 2 RESEARCH METHODOLOGY 45 2.1 RESEARCH DATA 45 2.1.1 SECONDARY DATA 45 2.1.1.1 Key data from secondary sources 46 2.1.2 PRIMARY DATA 47 2.1.2.1 Key data from primary sources 48 2.1.2.2 Key industry insights 49 2.2 MARKET SIZE ESTIMATION 50 2.2.1 CAGR PROJECTIONS 54 2.2.2 TOP-DOWN APPROACH 55 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 57 2.4 MARKET SHARE ESTIMATION 58 2.5 STUDY ASSUMPTIONS 58 2.6 LIMITATIONS 58 2.6.1 METHODOLOGY-RELATED LIMITATIONS 58 2.7 RISK ASSESSMENT 59 3 EXECUTIVE SUMMARY 60 4 PREMIUM INSIGHTS 65 4.1 OPHTHALMIC EQUIPMENT MARKET OVERVIEW 65 4.2 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY AND END USER (2024) 66 4.3 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 67 4.4 OPHTHALMIC EQUIPMENT MARKET, BY REGION (2025─2030) 68 4.5 OPHTHALMIC EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 68 5 MARKET OVERVIEW 69 5.1 INTRODUCTION 69 5.2 MARKET DYNAMICS 69 5.2.1 DRIVERS 70 5.2.1.1 Increasing geriatric population 70 5.2.1.2 Rising prevalence of eye disorders 71 5.2.1.2.1 Cataracts 71 5.2.1.2.2 Glaucoma 72 5.2.1.2.3 Obesity and diabetes 73 5.2.1.2.4 Age-related macular degeneration (AMD) 73 5.2.1.3 Technological advancements in ophthalmic devices 74 5.2.1.4 Increased government initiatives to control visual impairment 74 5.2.2 RESTRAINTS 75 5.2.2.1 High cost and risk associated with eye surgeries 75 5.2.2.2 High cost of ophthalmology devices 75 5.2.2.3 Rising adoption of refurbished ophthalmic devices 76 5.2.3 OPPORTUNITIES 77 5.2.3.1 Potential growth opportunities in emerging markets 77 5.2.3.2 Low adoption of phacoemulsification devices and premium IOLs in emerging markets 77 5.2.4 CHALLENGES 78 5.2.4.1 Low accessibility to eye care in low-income countries 78 5.2.4.2 Lack of skilled professionals 78 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79 5.4 PRICING ANALYSIS 80 5.4.1 AVERAGE SELLING PRICE OF OPHTHLAMIC EQUIPMENT PRODUCTS, BY KEY PLAYER, 2024 80 5.4.2 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 81 5.5 VALUE CHAIN ANALYSIS 82 5.6 SUPPLY CHAIN ANALYSIS 83 5.7 ECOSYSTEM ANALYSIS 84 5.8 INVESTMENT & FUNDING SCENARIO 85 5.9 TECHNOLOGY ANALYSIS 87 5.9.1 KEY TECHNOLOGIES 87 5.9.1.1 Robotics & image-guided surgical systems 87 5.9.1.2 Wearable and AR/VR-based vision systems 87 5.9.2 COMPLEMENTARY TECHNOLOGIES 88 5.9.2.1 Teleophthalmology and remote monitoring 88 5.9.2.2 Cloud connectivity and data integration 88 5.9.3 ADJACENT TECHNOLOGIES 88 5.9.3.1 Eye-tracking and motion compensation devices 88 5.9.3.2 Data management & EHR integration tools 89 5.10 INDUSTRY TRENDS 89 5.10.1 INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY 89 5.10.2 MINIMALLY INVASIVE GLAUCOMA SURGERY 90 5.11 PATENT ANALYSIS 90 5.12 TRADE ANALYSIS 92 5.12.1 IMPORT DATA (HS CODE 901850) 92 5.12.2 EXPORT DATA (HS CODE 901850) 93 5.13 KEY CONFERENCES & EVENTS, 2025–2026 94 5.14 CASE STUDY ANALYSIS 95 5.14.1 CASE STUDY 1: ZEISS – AI INTEGRATION IN CIRRUS OCT SYSTEMS 95 5.14.2 CASE STUDY 2: INDIAN GOVERNMENT’S NPCB & USE OF FORUS HEALTH’S 3NETHRA 95 5.14.3 CASE STUDY 3: HEIDELBERG ENGINEERING – NHS UK OCT DEPLOYMENT 96 5.15 REGULATORY ANALYSIS 96 5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 5.15.2 REGULATORY LANDSCAPE 98 5.15.2.1 North America 98 5.15.2.1.1 US 98 5.15.2.1.2 Canada 98 5.15.2.2 Europe 99 5.15.2.2.1 Germany 99 5.15.2.2.2 France 99 5.15.2.2.3 UK 99 5.15.2.3 Asia Pacific 99 5.15.2.3.1 China 99 5.15.2.3.2 Japan 99 5.15.2.3.3 India 100 5.15.2.4 Latin America 100 5.15.2.4.1 Brazil 100 5.15.2.4.2 Mexico 100 5.15.2.5 Middle East & Africa 100 5.15.2.5.1 Saudi Arabia 100 5.15.2.5.2 UAE 100 5.15.2.5.3 South Africa 101 5.15.2.5.4 Nigeria 101 5.16 PORTER’S FIVE FORCES ANALYSIS 101 5.16.1 THREAT OF NEW ENTRANTS 103 5.16.2 THREAT OF SUBSTITUTES 103 5.16.3 BARGAINING POWER OF BUYERS 103 5.16.4 BARGAINING POWER OF SUPPLIERS 103 5.16.5 INTENSITY OF COMPETITIVE RIVALRY 104 5.17 KEY STAKEHOLDERS & BUYING CRITERIA 104 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 104 5.17.2 BUYING CRITERIA 105 5.18 UNMET NEEDS/END-USER EXPECTATIONS 106 5.19 IMPACT OF 2025 US TARIFFS ON OPHTHALMIC EQUIPMENT MARKET 106 5.19.1 KEY TARIFF RATES 107 5.19.2 PRICE IMPACT ANALYSIS 108 5.19.3 KEY IMPACT ON COUNTRY/REGION 108 5.19.3.1 US 108 5.19.3.2 Europe 108 5.19.3.3 Asia Pacific 109 5.19.4 IMPACT ON END-USER INDUSTRIES 109 5.20 IMPACT OF ARTIFICIAL INTELLIGENCE ON OPHTHALMIC EQUIPMENT MARKET 109 5.21 ADJACENT MARKET ANALYSIS 110 6 OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY 111 6.1 INTRODUCTION 112 6.2 NON-AI-ENABLED EQUIPMENT 112 6.2.1 RISING SURGICAL VOLUMES AND AFFORDABILITY TO DRIVE NON-AI EQUIPMENT ADOPTION 112 6.3 AI-ENABLED EQUIPMENT 114 6.3.1 RISING DEMAND FOR PRECISION DIAGNOSTICS TO ACCELERATE AI-ENABLED EQUIPMENT ADOPTION 114 7 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT 117 7.1 INTRODUCTION 118 7.2 SURGICAL DEVICES 118 7.2.1 CATARACT SURGICAL DEVICES 120 7.2.1.1 Ophthalmic viscoelastic devices 122 7.2.1.1.1 Increasing number of cataract surgeries to support market growth 122 7.2.1.2 Phacoemulsification devices 125 7.2.1.2.1 Advancements in phacoemulsification devices to increase demand during forecast period 125 7.2.1.3 Cataract surgical lasers 127 7.2.1.3.1 Advantages such as high safety and accuracy to drive market growth 127 7.2.1.4 IOL injectors 129 7.2.1.4.1 Rising need for accurate implantation of IOLs to boost market growth 129 7.2.1.5 Intraocular lenses 131 7.2.1.5.1 Rising prevalence of cataracts globally to propel segment 131 7.2.2 VITREORETINAL SURGICAL DEVICES 134 7.2.2.1 Vitrectomy machines 135 7.2.2.1.1 Extensive usage of vitrectomy machines to correct retinal errors to boost market 135 7.2.2.2 Vitreoretinal packs 137 7.2.2.2.1 Increasing awareness about vitreoretinal surgery to increase utilization of vitreoretinal packs 137 7.2.2.3 Photocoagulation lasers 139 7.2.2.3.1 Rising prevalence of various eye diseases to drive market growth 139 7.2.2.4 Illumination devices 141 7.2.2.4.1 Growing use of portable, powerful illuminators for greater efficiency to fuel market growth 141 7.2.2.5 Vitrectomy probes 143 7.2.2.5.1 Advancements in vitrectomy probes to result in rapid cutting speed to remove vitreous bodies 143 7.2.2.6 Backflushes 145 7.2.2.6.1 Growing use of backflushes to prevent damage or complications to eye structure to propel growth 145 7.2.2.7 Chandeliers 147 7.2.2.7.1 Growing use of chandeliers for improved visualization of retina to aid growth 147 7.2.3 REFRACTIVE SURGICAL DEVICES 149 7.2.3.1 Femtosecond lasers 151 7.2.3.1.1 Rising preference for femtosecond lasers over microkeratomes to support market growth 151 7.2.3.2 Excimer lasers 153 7.2.3.2.1 Rising prevalence of myopia to drive market 153 7.2.3.3 Other refractive surgical devices 155 7.2.4 GLAUCOMA SURGICAL DEVICES 156 7.2.4.1 Microinvasive glaucoma surgery devices 158 7.2.4.1.1 Growing preference for microinvasive glaucoma surgery to drive adoption 158 7.2.4.2 Glaucoma drainage devices 160 7.2.4.2.1 Rising prevalence of glaucoma across globe to drives market growth 160 7.2.4.3 Glaucoma laser systems 162 7.2.4.3.1 Increasing prevalence of open-angle glaucoma to boost segment 162 7.2.5 OPHTHALMIC MICROSCOPES 164 7.2.5.1 Increasing prevalence of eye diseases to drive demand 164 7.2.6 OPHTHALMIC SURGICAL ACCESSORIES 166 7.2.6.1 Surgical instruments & kits 168 7.2.6.1.1 Surgical instruments & kits to hold largest share of accessories market 168 7.2.6.2 Ophthalmic tips & handles 170 7.2.6.2.1 Wide range of tips and handles available to meet end-user demand 170 7.2.6.3 Ophthalmic scissors 171 7.2.6.3.1 Growing end-user preference for titanium scissors to boost market 171 7.2.6.4 Ophthalmic forceps 172 7.2.6.4.1 Wide use of forceps in ophthalmological surgeries to drive demand 172 7.2.6.5 Ophthalmic spatulas 173 7.2.6.5.1 China to be fastest-growing market for ophthalmic spatulas 173 7.2.6.6 Macular lenses 174 7.2.6.6.1 Rise in adoption of macular lenses for hands-free operation to support growth 174 7.2.6.7 Ophthalmic cannulas 175 7.2.6.7.1 Rising adoption of single-use cannulas to drive market growth 175 7.2.6.8 Other ophthalmic surgical accessories 176 7.3 DIAGNOSTIC & MONITORING DEVICES 176 7.3.1 OPTICAL COHERENCE TOMOGRAPHY SCANNERS 178 7.3.1.1 Spectral-domain OCT (SD-OCT) 181 7.3.1.1.1 Growing demand for high-resolution retinal imaging to accelerate spectral-domain OCT adoption 181 7.3.1.2 Swept-source OCT (SS-OCT) 183 7.3.1.2.1 Rising preference for deep tissue imaging and faster scanning to fuel swept-source OCT demand 183 7.3.1.3 Handheld OCT 184 7.3.1.3.1 Surging demand for portability and pediatric imaging to propel handheld OCT system adoption 184 7.3.2 FUNDUS CAMERAS 186 7.3.2.1 Rising prevalence of age-related disorders to boost segment 186 7.3.3 PERIMETERS/VISUAL FIELD ANALYZERS 188 7.3.3.1 Increasing incidence of glaucoma and AMD to drive demand for perimeters 188 7.3.4 AUTOREFRACTORS & KERATOMETERS 190 7.3.4.1 Rising patient population with visual impairment to drive utilization 190 7.3.5 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 193 7.3.5.1 Ophthalmic A-scan ultrasound 195 7.3.5.1.1 Wide usage to measure length of eye in common eye disorders to boost market 195 7.3.5.2 Ophthalmic B-scan ultrasound 197 7.3.5.2.1 Growing use of B-scans to assess eye and orbit to determine eye disorders 197 7.3.5.3 Ophthalmic ultrasound biomicroscopes 198 7.3.5.3.1 Rising volume of refractive surgeries to fuel market growth 198 7.3.5.4 Ophthalmic pachymeters 201 7.3.5.4.1 Growing use of ophthalmic pachymeters to monitor condition of cornea to support growth 201 7.3.6 OTHER OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 202 7.3.7 TONOMETERS 204 7.3.7.1 Rising prevalence of glaucoma to boost demand 204 7.3.8 SLIT LAMPS 206 7.3.8.1 Rising prevalence of ocular conditions to drive market 206 7.3.9 PHOROPTERS 209 7.3.9.1 Phoropters aid in measurement of refractive errors 209 7.3.10 WAVEFRONT ABERROMETERS 211 7.3.10.1 Effectiveness in measuring refractive aberrations to drive demand 211 7.3.11 OPTICAL BIOMETRY SYSTEMS 213 7.3.11.1 Advantages of optical biometry systems to boost adoption in diagnostics 213 7.3.12 OPHTHALMOSCOPES 215 7.3.12.1 Increasing number of patients with glaucoma, diabetic retinopathy, and AMD to fuel market 215 7.3.13 LENSMETERS 217 7.3.13.1 Rising prevalence of myopia & hyperopia to fuel growth 217 7.3.14 CORNEAL TOPOGRAPHY SYSTEMS 219 7.3.14.1 Increasing number of LASIK procedures to drive demand 219 7.3.15 CHART PROJECTORS 221 7.3.15.1 Ability to provide practitioners access to multiple chart types in one device to boost demand 221 7.3.16 SPECULAR MICROSCOPES 223 7.3.16.1 Growing number of patients with diabetes to drive market 223 7.3.17 RETINOSCOPES 225 7.3.17.1 Rising prevalence of myopia across globe to boost market growth 225 7.3.18 OTHER DIAGNOSTIC & MONITORING DEVICES 227 8 OPHTHALMIC EQUIPMENT MARKET, BY END USER 229 8.1 INTRODUCTION 230 8.2 HOSPITALS 230 8.2.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS TO DRIVE GROWTH 230 8.3 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS 232 8.3.1 COST-EFFECTIVENESS OF AMBULATORY CARE TO ENHANCE END-USER INTEREST 232 8.4 OTHER END USERS 233 9 OPHTHALMIC EQUIPMENT MARKET, BY REGION 235 9.1 INTRODUCTION 236 9.2 NORTH AMERICA 237 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 238 9.2.2 US 244 9.2.2.1 Rising geriatric population and increasing healthcare expenditure to drive market 244 9.2.3 CANADA 251 9.2.3.1 Rising awareness about eye care and increasing ocular diseases to drive market 251 9.3 EUROPE 256 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 257 9.3.2 GERMANY 262 9.3.2.1 Increasing healthcare expenditure to boost market 262 9.3.3 UK 268 9.3.3.1 Rising prevalence of diabetes-related eye diseases to drive market 268 9.3.4 FRANCE 273 9.3.4.1 Growing number of eye surgeries to drive demand 273 9.3.5 ITALY 279 9.3.5.1 Increasing healthcare spending and growing geriatric population to propel market 279 9.3.6 SPAIN 285 9.3.6.1 Increasing ophthalmic surgical procedures to drive market 285 9.3.7 REST OF EUROPE 290 9.4 ASIA PACIFIC 296 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 297 9.4.2 CHINA 303 9.4.2.1 Rising prevalence of cataracts to drive market 303 9.4.3 JAPAN 309 9.4.3.1 Strong manufacturing capabilities to propel market 309 9.4.4 INDIA 316 9.4.4.1 Increasing geriatric population and prevalence of eye disorders to support market 316 9.4.5 AUSTRALIA 320 9.4.5.1 Increased cataract surgeries to drive market 320 9.4.6 SOUTH KOREA 326 9.4.6.1 Growing focus on medical tourism to boost market 326 9.4.7 REST OF ASIA PACIFIC 332 9.5 LATIN AMERICA 337 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 338 9.5.2 BRAZIL 344 9.5.2.1 Government support and initiatives to boost market 344 9.5.3 MEXICO 350 9.5.3.1 Growing incidence of eye disorders to drive market 350 9.5.4 ARGENTINA 356 9.5.4.1 Increasing healthcare expenditure and well-developed healthcare system to favor market 356 9.5.5 REST OF LATIN AMERICA 362 9.6 MIDDLE EAST & AFRICA 369 9.6.1 IMPROVING HEALTHCARE EXPENDITURE TO DRIVE MARKET 369 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 369 9.7 GCC COUNTRIES 374 9.7.1 RISING CATARACT PREVALENCE AND ADOPTION OF ADVANCED OPHTHALMIC TECHNOLOGIES TO DRIVE GROWTH 374 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 375 10 COMPETITIVE LANDSCAPE 381 10.1 OVERVIEW 381 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 381 10.3 REVENUE ANALYSIS, 2020–2024 383 10.4 MARKET SHARE ANALYSIS, 2024 385 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 386 10.5.1 STARS 386 10.5.2 EMERGING LEADERS 386 10.5.3 PERVASIVE PLAYERS 387 10.5.4 PARTICIPANTS 387 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 388 10.5.5.1 Company footprint 388 10.5.5.2 Region footprint 389 10.5.5.3 Product footprint 390 10.5.5.4 End-user footprint 391 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 392 10.6.1 PROGRESSIVE COMPANIES 392 10.6.2 RESPONSIVE COMPANIES 392 10.6.3 DYNAMIC COMPANIES 392 10.6.4 STARTING BLOCKS 392 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 394 10.6.5.1 Detailed list of key startups/SMEs 394 10.6.5.2 Competitive benchmarking of key startups/SMEs 395 10.7 COMPANY VALUATION & FINANCIAL METRICS 396 10.7.1 FINANCIAL METRICS 396 10.7.2 COMPANY VALUATION 396 10.8 BRAND/PRODUCT COMPARISON 397 10.9 COMPETITIVE SCENARIO 398 10.9.1 PRODUCT LAUNCHES & APPROVALS 398 10.9.2 DEALS 400   11 COMPANY PROFILES 404 11.1 KEY PLAYERS 404 11.1.1 ALCON 404 11.1.1.1 Business overview 404 11.1.1.2 Products offered 405 11.1.1.3 Recent developments 406 11.1.1.3.1 Product launches 406 11.1.1.3.2 Deals 407 11.1.1.4 MnM view 407 11.1.1.4.1 Right to win 407 11.1.1.4.2 Strategic choices 407 11.1.1.4.3 Weaknesses & competitive threats 408 11.1.2 JOHNSON & JOHNSON 409 11.1.2.1 Business overview 409 11.1.2.2 Products offered 410 11.1.2.3 Recent developments 412 11.1.2.3.1 Product launches 412 11.1.2.4 MnM view 412 11.1.2.4.1 Right to win 412 11.1.2.4.2 Strategic choices 412 11.1.2.4.3 Weaknesses & competitive threats 412 11.1.3 CARL ZEISS MEDITEC AG 413 11.1.3.1 Business overview 413 11.1.3.2 Products offered 414 11.1.3.3 Recent developments 416 11.1.3.3.1 Product launches 416 11.1.3.3.2 Deals 416 11.1.3.4 MnM view 417 11.1.3.4.1 Right to win 417 11.1.3.4.2 Strategic choices 417 11.1.3.4.3 Weaknesses & competitive threats 417 11.1.4 BAUSCH HEALTH COMPANIES INC. 418 11.1.4.1 Business overview 418 11.1.4.2 Products offered 420 11.1.4.3 Recent developments 420 11.1.4.3.1 Product launches 420 11.1.4.3.2 Deals 421 11.1.4.4 MnM view 421 11.1.4.4.1 Right to win 421 11.1.4.4.2 Strategic choices 421 11.1.4.4.3 Weaknesses & competitive threats 421   11.1.5 HOYA CORPORATION 422 11.1.5.1 Business overview 422 11.1.5.2 Products offered 423 11.1.5.2.1 Deals 424 11.1.5.3 MnM view 425 11.1.5.3.1 Right to win 425 11.1.5.3.2 Strategic choices 425 11.1.5.3.3 Weaknesses & competitive threats 425 11.1.6 ESSILORLUXOTTICA 426 11.1.6.1 Business overview 426 11.1.6.2 Products offered 426 11.1.6.3 Recent developments 428 11.1.6.3.1 Deals 428 11.1.7 CANON 429 11.1.7.1 Business overview 429 11.1.7.2 Products offered 431 11.1.8 GLAUKOS CORPORATION 432 11.1.8.1 Business overview 432 11.1.8.2 Products offered 433 11.1.8.3 Recent developments 434 11.1.8.3.1 Product approvals 434 11.1.8.3.2 Deals 434 11.1.9 TOPCON CORPORATION 435 11.1.9.1 Business overview 435 11.1.9.2 Products offered 436 11.1.9.3 Recent developments 438 11.1.9.3.1 Product launches 438 11.1.9.3.2 Deals 438 11.1.10 NIDEK CO., LTD. 439 11.1.10.1 Business overview 439 11.1.10.2 Products offered 439 11.1.10.3 Recent developments 442 11.1.10.3.1 Product launches 442 11.1.10.3.2 Deals 442 11.1.11 STAAR SURGICAL 443 11.1.11.1 Business overview 443 11.1.11.2 Products offered 444 11.1.11.3 Recent developments 444 11.1.11.3.1 Product approvals 444 11.1.12 HALMA PLC 445 11.1.12.1 Business overview 445 11.1.12.2 Products offered 446 11.1.13 HAAG-STREIT 448 11.1.13.1 Business overview 448 11.1.13.2 Products offered 448 11.1.13.3 Recent developments 449 11.1.13.3.1 Product launches 449 11.1.13.3.2 Deals 450 11.1.14 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD. 451 11.1.14.1 Business overview 451 11.1.14.2 Products offered 451 11.1.15 VISIONIX 452 11.1.15.1 Business overview 452 11.1.15.2 Products offered 452 11.1.15.3 Recent developments 453 11.1.15.3.1 Deals 453 11.2 OTHER PLAYERS 454 11.2.1 VISUNEX MEDICAL SYSTEMS 454 11.2.2 COSTRUZIONE STRUMENTI OFTALMICI 455 11.2.3 HAI LABORATORIES, INC. 456 11.2.4 FORUS HEALTH 457 11.2.5 ZIEMER OPHTHALMIC SYSTEMS AG 458 11.2.6 CRYSTALVUE MEDICAL CORPORATION 459 11.2.7 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD. 460 11.2.8 SUZHOU KANGJIE MEDICAL INC. 461 11.2.9 LUMENIS 462 11.2.10 OPHTEC BV 463 12 APPENDIX 464 12.1 DISCUSSION GUIDE 464 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 470 12.3 CUSTOMIZATION OPTIONS 472 12.4 RELATED REPORTS 472 12.5 AUTHOR DETAILS 473
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 42 TABLE 2 RISK ASSESSMENT: OPHTHALMIC EQUIPMENT MARKET 59 TABLE 3 INCREASE IN GERIATRIC POPULATION, 2000–2050 70 TABLE 4 GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2024 (IN MILLION) 71 TABLE 5 NUMBER OF CATARACT SURGERIES, BY COUNTRY (2023 VS. 2024) 72 TABLE 6 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS. 2040 (MILLION) 72 TABLE 7 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS. 2045 (MILLION) 73 TABLE 8 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS. 2050 (MILLION) 74 TABLE 9 PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2022) 76 TABLE 10 AVERAGE SELLING PRICE OF OPHTHALMIC EQUIPMENT PRODUCTS, BY KEY PLAYER, 2024 (USD) 80 TABLE 11 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD) 81 TABLE 12 OPHTHALMIC EQUIPMENT MARKET: ROLE OF COMPANIES IN ECOSYSTEM 85 TABLE 13 IMPORT DATA FOR HS CODE 901850-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 92 TABLE 14 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 93 TABLE 15 OPHTHALMIC EQUIPMENT MARKET: KEY CONFERENCES & EVENTS, 2025–2026 94 TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 21 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 102 TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 104 TABLE 23 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 105 TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 107 TABLE 25 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ECMO MACHINES 108 TABLE 26 OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 112 TABLE 27 NON-AI-ENABLED EQUIPMENT OFFERED BY KEY PLAYERS 113 TABLE 28 NON-AI-ENABLED OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 29 AI-ENABLED EQUIPMENT OFFERED BY KEY PLAYERS 115 TABLE 30 AI-ENABLED OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 31 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 118 TABLE 32 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 119 TABLE 33 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 34 CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 121 TABLE 35 CATARACT SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 36 OPHTHALMIC VISCOELASTIC DEVICES OFFERED BY KEY MARKET PLAYERS 123 TABLE 37 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 38 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 125 TABLE 39 PHACOEMULSIFICATION OFFERED BY KEY MARKET PLAYERS 126 TABLE 40 PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 41 PHACOEMULSIFICATION DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 127 TABLE 42 CATARACT SURGICAL LASERS OFFERED BY KEY MARKET PLAYERS 128 TABLE 43 CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 44 CATARACT SURGICAL LASERS MARKET, BY REGION, 2023–2030 (UNITS) 129 TABLE 45 IOL INJECTORS OFFERED BY KEY PLAYERS 129 TABLE 46 IOL INJECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 47 IOL INJECTORS MARKET, BY REGION, 2023–2030 (UNITS) 131 TABLE 48 INTRAOCULAR LENSES OFFERED BY KEY PLAYERS 132 TABLE 49 INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 50 INTRAOCULAR LENSES MARKET, BY REGION, 2023–2030 (UNITS) 133 TABLE 51 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 134 TABLE 52 VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 53 VITRECTOMY MACHINES OFFERED BY KEY MARKET PLAYERS 136 TABLE 54 VITRECTOMY MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 55 VITRECTOMY MACHINES MARKET, BY REGION, 2023–2030 (UNITS) 137 TABLE 56 VITREORETINAL PACKS OFFERED BY KEY MARKET PLAYERS 137 TABLE 57 VITREORETINAL PACKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 58 VITREORETINAL PACKS MARKET, BY REGION, 2023–2030 (UNITS) 138 TABLE 59 PHOTOCOAGULATION LASERS OFFERED BY KEY MARKET PLAYERS 139 TABLE 60 PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 61 PHOTOCOAGULATION LASERS MARKET, BY REGION, 2023–2030 (UNITS) 141 TABLE 62 ILLUMINATION DEVICES OFFERED BY KEY MARKET PLAYERS 141 TABLE 63 ILLUMINATION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 64 ILLUMINATION DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 143 TABLE 65 VITRECTOMY PROBES OFFERED BY KEY MARKET PLAYERS 143 TABLE 66 VITRECTOMY PROBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 67 VITRECTOMY PROBES MARKET, BY REGION, 2023–2030 (UNITS) 145 TABLE 68 BACKFLUSHES OFFERED BY KEY MARKET PLAYERS 145 TABLE 69 BACKFLUSHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 70 BACKFLUSHES MARKET, BY REGION, 2023–2030 (UNITS) 147 TABLE 71 CHANDELIERS OFFERED BY KEY MARKET PLAYERS 147 TABLE 72 CHANDELIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 73 CHANDELIERS MARKET, BY REGION, 2023–2030 (UNITS) 149 TABLE 74 REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 75 REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 76 FEMTOSECOND LASERS OFFERED BY KEY MARKET PLAYERS 151 TABLE 77 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 78 FEMTOSECOND LASERS MARKET, BY REGION, 2023–2030 (UNITS) 153 TABLE 79 EXCIMER LASERS OFFERED BY KEY MARKET PLAYERS 154 TABLE 80 EXCIMER LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 81 EXCIMER LASERS MARKET, BY REGION, 2023–2030 (UNITS) 155 TABLE 82 OTHER REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 83 GLAUCOMA SURGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 157 TABLE 84 GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 85 GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 86 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 87 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 160 TABLE 88 GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 89 GLAUCOMA DRAINAGE DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 162 TABLE 90 GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 91 GLAUCOMA LASER SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 164 TABLE 92 OPHTHALMIC MICROSCOPES OFFERED BY KEY MARKET PLAYERS 165 TABLE 93 OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 94 OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY MARKET PLAYERS 166 TABLE 95 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 96 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 97 SURGICAL INSTRUMENTS & KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 98 OPHTHALMIC TIPS & HANDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 99 OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 100 OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 101 OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 102 MACULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 103 OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 104 OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 105 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 106 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 107 OCT SCANNERS OFFERED BY KEY MARKET PLAYERS 179 TABLE 108 OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 109 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 110 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY REGION, 2023–2030 (UNITS) 181 TABLE 111 SPECTRAL-DOMAIN OCT (SD-OCT) SYSTEMS OFFERED BY KEY MARKET PLAYERS 182 TABLE 112 SPECTRAL-DOMAIN OCT (SD-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 113 SWEPT-SOURCE OCT (SS-OCT) SYSTEMS OFFERED BY KEY MARKET PLAYERS 183 TABLE 114 SWEPT-SOURCE OCT (SS-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 115 EXAMPLES OF HANDHELD OCT 185 TABLE 116 HANDHELD OCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 117 FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS 186 TABLE 118 FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 119 FUNDUS CAMERAS MARKET, BY REGION, 2023–2030 (UNITS) 188 TABLE 120 PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS 189 TABLE 121 PERIMETERS/VISUAL FIELD ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 122 PERIMETERS/VISUAL FIELD ANALYZERS MARKET, BY REGION, 2023–2030 (UNITS) 190 TABLE 123 AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS 191 TABLE 124 AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 125 AUTOREFRACTORS & KERATOMETERS MARKET, BY REGION, 2023–2030 (UNITS) 193 TABLE 126 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 127 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 128 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 195 TABLE 129 OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS OFFERED BY KEY MARKET PLAYERS 196 TABLE 130 OPHTHALMIC A-SCAN ULTRASOUND MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 131 OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS OFFERED BY KEY MARKET PLAYERS 197 TABLE 132 OPHTHALMIC B-SCAN ULTRASOUND MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 133 OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED BY KEY MARKET PLAYERS 199 TABLE 134 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 135 OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS 201 TABLE 136 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 137 OTHER OPHTHALMIC ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 203 TABLE 138 OTHER OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 139 TONOMETERS OFFERED BY KEY MARKET PLAYERS 204 TABLE 140 TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 141 TONOMETERS MARKET, BY REGION, 2023–2030 (UNITS) 206 TABLE 142 SLIT LAMPS OFFERED BY KEY MARKET PLAYERS 207 TABLE 143 SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 144 SLIT LAMPS MARKET, BY REGION, 2023–2030 (UNITS) 209 TABLE 145 PHOROPTERS OFFERED BY KEY MARKET PLAYERS 209 TABLE 146 PHOROPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 147 PHOROPTERS MARKET, BY REGION, 2023–2030 (UNITS) 211 TABLE 148 WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS 211 TABLE 149 WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 150 WAVEFRONT ABERROMETERS MARKET, BY REGION, 2023–2030 (UNITS) 213 TABLE 151 OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS 214 TABLE 152 OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 153 OPTICAL BIOMETRY SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 215 TABLE 154 OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS 216 TABLE 155 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 156 OPHTHALMOSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 217 TABLE 157 LENSMETERS OFFERED BY KEY MARKET PLAYERS 217 TABLE 158 LENSMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 159 LENSMETERS MARKET, BY REGION, 2023–2030 (UNITS) 219 TABLE 160 CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS 219 TABLE 161 CORNEAL TOPOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 162 CORNEAL TOPOGRAPHY SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 220 TABLE 163 CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS 221 TABLE 164 CHART PROJECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 165 CHART PROJECTORS MARKET, BY REGION, 2023–2030 (UNITS) 222 TABLE 166 SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS 223 TABLE 167 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 168 SPECULAR MICROSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 224 TABLE 169 RETINOSCOPES OFFERED BY KEY MARKET PLAYERS 225 TABLE 170 RETINOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 171 RETINOSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 226 TABLE 172 OTHER DIAGNOSTIC & MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 173 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 174 OPHTHALMIC EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 175 OPHTHALMIC EQUIPMENT MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 176 OPHTHALMIC EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 177 OPHTHALMIC EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION) 236 TABLE 178 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 179 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 239 TABLE 180 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 239 TABLE 181 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 182 NORTH AMERICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 183 NORTH AMERICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 184 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 185 NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 186 NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 187 NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 188 NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 189 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 244 TABLE 190 US: OPHTHALMIC EQUIPMENT MARKET, VOLUME, 2023–2030 (UNITS) 245 TABLE 191 US: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 246 TABLE 192 US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 246 TABLE 193 US: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 194 US: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 195 US: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 196 US: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 197 US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 198 US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 199 US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 200 US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 201 US: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 251 TABLE 202 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 252 TABLE 203 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 252 TABLE 204 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 205 CANADA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 206 CANADA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 207 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 208 CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 209 CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 210 CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 211 CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 212 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 256 TABLE 213 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 214 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 257 TABLE 215 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 258 TABLE 216 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 217 EUROPE: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 218 EUROPE: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 219 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 220 EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 221 EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 222 EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 223 EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 224 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 225 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 263 TABLE 226 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 263 TABLE 227 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 228 GERMANY: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 229 GERMANY: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 230 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 231 GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 232 GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 233 GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 234 GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 235 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 268 TABLE 236 UK: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 269 TABLE 237 UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 269 TABLE 238 UK: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 239 UK: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 240 UK: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 241 UK: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 242 UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 243 UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 244 UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 245 UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 246 UK: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 247 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 274 TABLE 248 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274 TABLE 249 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 250 FRANCE: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 251 FRANCE: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 252 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 253 FRANCE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 254 FRANCE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 255 FRANCE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 256 FRANCE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 257 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 279 TABLE 258 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 280 TABLE 259 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 280 TABLE 260 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 261 ITALY: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 262 ITALY: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 263 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 264 ITALY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 265 ITALY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 266 ITALY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 267 ITALY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 268 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 269 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 285 TABLE 270 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 286 TABLE 271 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 272 SPAIN: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 273 SPAIN: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 274 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 275 SPAIN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 276 SPAIN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 277 SPAIN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 278 SPAIN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 279 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 280 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 291 TABLE 281 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 291 TABLE 282 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 283 REST OF EUROPE: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 284 REST OF EUROPE: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 285 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 286 REST OF EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 287 REST OF EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 288 REST OF EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 289 REST OF EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 290 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 296 TABLE 291 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 298 TABLE 292 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 298 TABLE 293 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 298 TABLE 294 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 295 ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 296 ASIA PACIFIC: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 297 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 298 ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 299 ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 300 ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 301 ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 302 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 303 TABLE 303 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 304 TABLE 304 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 304 TABLE 305 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 306 CHINA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 307 CHINA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 308 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 309 CHINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 310 CHINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 311 CHINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 312 CHINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 313 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 309 TABLE 314 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 310 TABLE 315 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 310 TABLE 316 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 317 JAPAN: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 318 JAPAN: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 319 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 320 JAPAN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 321 JAPAN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 322 JAPAN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 323 JAPAN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 324 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 315 TABLE 325 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 316 TABLE 326 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 316 TABLE 327 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 328 INDIA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 329 INDIA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 330 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 331 INDIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 332 INDIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 333 INDIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 334 INDIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 335 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 320 TABLE 336 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 321 TABLE 337 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 321 TABLE 338 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 339 AUSTRALIA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 340 AUSTRALIA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 341 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 342 AUSTRALIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 343 AUSTRALIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 344 AUSTRALIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 345 AUSTRALIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 346 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 326 TABLE 347 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 327 TABLE 348 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 327 TABLE 349 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 350 SOUTH KOREA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 351 SOUTH KOREA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 352 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 353 SOUTH KOREA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 354 SOUTH KOREA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 355 SOUTH KOREA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 356 SOUTH KOREA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 357 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 332 TABLE 358 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 332 TABLE 359 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 333 TABLE 360 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 361 REST OF ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 362 REST OF ASIA PACIFIC: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 363 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 364 REST OF ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 365 REST OF ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 366 REST OF ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 367 REST OF ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 368 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 337 TABLE 369 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 338 TABLE 370 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 339 TABLE 371 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 339 TABLE 372 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 373 LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 374 LATIN AMERICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 375 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 376 LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 377 LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 378 LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 379 LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 380 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 344 TABLE 381 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 345 TABLE 382 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 345 TABLE 383 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 384 BRAZIL: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 385 BRAZIL: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 386 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 387 BRAZIL: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 388 BRAZIL: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 389 BRAZIL: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 390 BRAZIL: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 391 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 350 TABLE 392 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 351 TABLE 393 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 351 TABLE 394 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 395 MEXICO: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 396 MEXICO: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 397 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 398 MEXICO: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 399 MEXICO: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 400 MEXICO: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 401 MEXICO: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 402 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 356 TABLE 403 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 357 TABLE 404 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 357 TABLE 405 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 406 ARGENTINA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 407 ARGENTINA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 408 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 409 ARGENTINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 410 ARGENTINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 411 ARGENTINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 412 ARGENTINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 413 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 362 TABLE 414 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 363 TABLE 415 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 363 TABLE 416 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 417 REST OF LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 418 REST OF LATIN AMERICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 419 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 420 REST OF LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 421 REST OF LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 422 REST OF LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 423 REST OF LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 424 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 368 TABLE 425 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 369 TABLE 426 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 370 TABLE 427 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 428 MIDDLE EAST & AFRICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,2023–2030 (USD MILLION) 371 TABLE 429 MIDDLE EAST & AFRICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,2023–2030 (USD MILLION) 371 TABLE 430 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 431 MIDDLE EAST & AFRICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 432 MIDDLE EAST & AFRICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 433 MIDDLE EAST & AFRICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 434 MIDDLE EAST & AFRICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 435 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 374 TABLE 436 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 375 TABLE 437 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 376 TABLE 438 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 439 GCC COUNTRIES: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 440 GCC COUNTRIES: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 441 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 442 GCC COUNTRIES: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 443 GCC COUNTRIES: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 379 TABLE 444 GCC COUNTRIES: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 379 TABLE 445 GCC COUNTRIES: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 446 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 380 TABLE 447 KEY DEVELOPMENTS IN OPHTHALMIC EQUIPMENT MARKET, JANUARY 2021–OCTOBER 2025 381 TABLE 448 OPHTHALMIC EQUIPMENT MARKET: DEGREE OF COMPETITION 385 TABLE 449 OPHTHALMIC EQUIPMENT MARKET: REGION FOOTPRINT 389 TABLE 450 OPHTHALMIC EQUIPMENT MARKET: PRODUCT FOOTPRINT 390 TABLE 451 OPHTHALMIC EQUIPMENT MARKET: END-USER FOOTPRINT 391 TABLE 452 OPHTHALMIC EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 394 TABLE 453 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 395 TABLE 454 OPHTHALMIC EQUIPMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2025 398 TABLE 455 OPHTHALMIC EQUIPMENT MARKET: DEALS, JANUARY 2021–OCTOBER 2025 400 TABLE 456 ALCON: COMPANY OVERVIEW 404 TABLE 457 ALCON: PRODUCTS OFFERED 405 TABLE 458 ALCON: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 406 TABLE 459 ALCON: DEALS, JANUARY 2021–OCTOBER 2025 407 TABLE 460 JOHNSON & JOHNSON: COMPANY OVERVIEW 409 TABLE 461 JOHNSON & JOHNSON: PRODUCTS OFFERED 410 TABLE 462 JOHNSON & JOHNSON: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 412 TABLE 463 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW 413 TABLE 464 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 414 TABLE 465 CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 416 TABLE 466 CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021–OCTOBER 2025 416 TABLE 467 BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW 418 TABLE 468 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED 420 TABLE 469 BAUSCH HEALTH COMPANIES INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 420 TABLE 470 BAUSCH HEALTH COMPANIES INC.: DEALS, JANUARY 2021–OCTOBER 2025 421 TABLE 471 HOYA CORPORATION: COMPANY OVERVIEW 422 TABLE 472 HOYA CORPORATION: PRODUCTS OFFERED 423 TABLE 473 HOYA CORPORATION: DEALS, JANUARY 2021–OCTOBER 2025 424 TABLE 474 ESSILORLUXOTTICA: COMPANY OVERVIEW 426 TABLE 475 ESSILORLUXOTTICA: PRODUCTS OFFERED 426 TABLE 476 ESSILORLUXOTTICA: DEALS, JANUARY 2021–OCTOBER 2025 428 TABLE 477 CANON: COMPANY OVERVIEW 429 TABLE 478 CANON: PRODUCTS OFFERED 431 TABLE 479 GLAUKOS CORPORATION: COMPANY OVERVIEW 432 TABLE 480 GLAUKOS CORPORATION: PRODUCTS OFFERED 433 TABLE 481 GLAUKOS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2025 434 TABLE 482 GLAUKOS CORPORATION: DEALS, JANUARY 2021–OCTOBER 2025 434 TABLE 483 TOPCON CORPORATION: COMPANY OVERVIEW 435 TABLE 484 TOPCON CORPORATION: PRODUCTS OFFERED 436 TABLE 485 TOPCON CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 438 TABLE 486 TOPCON CORPORATION: DEALS, JANUARY 2021–OCTOBER 2025 438 TABLE 487 NIDEK CO., LTD.: COMPANY OVERVIEW 439 TABLE 488 NIDEK CO., LTD.: PRODUCTS OFFERED 439 TABLE 489 NIDEK CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 442 TABLE 490 NIDEK CO., LTD.: DEALS, JANUARY 2021–OCTOBER 2025 442 TABLE 491 STAAR SURGICAL: COMPANY OVERVIEW 443 TABLE 492 STAAR SURGICAL: PRODUCTS OFFERED 444 TABLE 493 STAAR SURGICAL: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2025 444 TABLE 494 HALMA PLC: COMPANY OVERVIEW 445 TABLE 495 HALMA PLC: PRODUCTS OFFERED 446 TABLE 496 HAAG-STREIT: COMPANY OVERVIEW 448 TABLE 497 HAAG-STREIT: PRODUCTS OFFERED 448 TABLE 498 HAAG-STREIT: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 449 TABLE 499 HAAG-STREIT: DEALS, JANUARY 2021–OCTOBER 2025 450 TABLE 500 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 451 TABLE 501 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.: PRODUCTS OFFERED 451 TABLE 502 VISIONIX: COMPANY OVERVIEW 452 TABLE 503 VISIONIX: PRODUCTS OFFERED 452 TABLE 504 VISIONIX: DEALS, JANUARY 2021–JULY 2025 453 TABLE 505 VISUNEX MEDICAL SYSTEMS: COMPANY OVERVIEW 454 TABLE 506 COSTRUZIONE STRUMENTI OFTALMICI: COMPANY OVERVIEW 455 TABLE 507 HAI LABORATORIES, INC.: COMPANY OVERVIEW 456 TABLE 508 FORUS HEALTH: COMPANY OVERVIEW 457 TABLE 509 ZIEMER OPHTHALMIC SYSTEMS AG: COMPANY OVERVIEW 458 TABLE 510 CRYSTALVUE MEDICAL CORPORATION: COMPANY OVERVIEW 459 TABLE 511 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.: COMPANY OVERVIEW 460 TABLE 512 SUZHOU KANGJIE MEDICAL INC.: COMPANY OVERVIEW 461 TABLE 513 LUMENIS: COMPANY OVERVIEW 462 TABLE 514 OPHTEC BV: COMPANY OVERVIEW 463 FIGURE 1 OPHTHALMIC EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE 39 FIGURE 2 YEARS CONSIDERED 40 FIGURE 3 RESEARCH DESIGN 45 FIGURE 4 PRIMARY SOURCES 47 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 49 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 50 FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 51 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ALCON INC. 51 FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: OPHTHALMIC EQUIPMENT MARKET (2024) 52 FIGURE 10 BOTTOM-UP APPROACH: SURGICAL DEVICES COMPANY REVENUE ESTIMATION APPROACH 53 FIGURE 11 BOTTOM-UP APPROACH: DIAGNOSTIC & MONITORING DEVICES COMPANY REVENUE ESTIMATION APPROACH 53 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54 FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN OPHTHALMIC EQUIPMENT MARKET (2025–2030): IMPACT ON GROWTH & CAGR 56 FIGURE 14 DATA TRIANGULATION METHODOLOGY 57 FIGURE 15 OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 60 FIGURE 16 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 61 FIGURE 17 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2025 VS. 2030 (USD MILLION) 61 FIGURE 18 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2025 VS. 2030 (USD MILLION) 62 FIGURE 19 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 63 FIGURE 20 REGIONAL SNAPSHOT OF OPHTHALMIC EQUIPMENT MARKET 64 FIGURE 21 RISING PREVALENCE OF EYE DISEASES TO DRIVE MARKET GROWTH 65 FIGURE 22 HOSPITALS DOMINATED NORTH AMERICAN OPHTHALMIC EQUIPMENT MARKET IN 2024 66 FIGURE 23 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030 67 FIGURE 24 NORTH AMERICA TO LEAD MARKET UNTIL 2030 68 FIGURE 25 DEVELOPING MARKETS TO REGISTER FASTER GROWTH DURING FORECAST PERIOD 68 FIGURE 26 OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 69 FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79 FIGURE 28 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 81 FIGURE 29 OPHTHALMIC EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 82 FIGURE 30 OPHTHALMIC EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 83 FIGURE 31 OPHTHALMIC EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 84 FIGURE 32 OPHTHALMIC EQUIPMENT MARKET: INVESTMENT & FUNDING SCENARIO, 2019–2023 86 FIGURE 33 OPHTHALMIC EQUIPMENT MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 86 FIGURE 34 OPHTHALMIC EQUIPMENT MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 87 FIGURE 35 OPHTHALMIC EQUIPMENT MARKET: PATENT ANALYSIS, JANUARY 2015−OCTOBER 2025 91 FIGURE 36 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 102 FIGURE 37 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 104 FIGURE 38 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 105 FIGURE 39 OPHTHALMIC EQUIPMENT MARKET: IMPACT OF AI/GEN AI 110 FIGURE 40 OPHTHALMIC EQUIPMENT MARKET: ADJACENT MARKETS 110 FIGURE 41 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 237 FIGURE 42 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 238 FIGURE 43 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 297 FIGURE 44 REVENUE ANALYSIS OF TOP PLAYERS IN OPHTHALMIC EQUIPMENT MARKET, 2020–2024 (USD MILLION) 384 FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC EQUIPMENT MARKET, 2024 385 FIGURE 46 OPHTHALMIC EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 387 FIGURE 47 OPHTHALMIC EQUIPMENT MARKET: COMPANY FOOTPRINT 388 FIGURE 48 OPHTHALMIC EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 393 FIGURE 49 EV/EBITDA OF KEY VENDORS 396 FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 396 FIGURE 51 OPHTHALMIC EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON 397 FIGURE 52 ALCON: COMPANY SNAPSHOT (2024) 405 FIGURE 53 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 410 FIGURE 54 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2024) 414 FIGURE 55 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2024) 419 FIGURE 56 HOYA CORPORATION: COMPANY SNAPSHOT (2024) 423 FIGURE 57 CANON: COMPANY SNAPSHOT (2024) 430 FIGURE 58 GLAUKOS CORPORATION: COMPANY SNAPSHOT (2024) 433 FIGURE 59 TOPCON CORPORATION: COMPANY SNAPSHOT (2024) 436 FIGURE 60 STAAR SURGICAL: COMPANY SNAPSHOT (2024) 443 FIGURE 61 HALMA PLC: COMPANY SNAPSHOT (2024) 446

同分類最新報告(醫療器材)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們